Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Leiomyosarcoma.

SAINT study is currently investigating intravenous trabectedin plus ipilimumab and nivolumab in the first line for advanced ...

For patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and trabectedin is associated with improved overall and progression-free survival compared ...

Sarcomas are highly metastatic soft tissue and bone cancers and are often difficult to treat. Scientists have had trouble ...

OS rates were 68% in the doxorubicin-trabectedin group and 49% in the doxorubicin-alone group, and the 2-year PFS rates were ...

Megan Nelson, Capturing the Moment Founder, said. Rick Fow, who was diagnosed with a vary rare cancer called leiomyosarcoma, ...

Preliminary data presented at ESMO 2024 demonstrate that BT-001 induces tumor regression in patients who failed previous anti-PD(L)-1 treatmentIn a patient with a heavily pretreated leiomyosarcoma, BT ...

Pamiparib (Baihuize) is an anti-neoplastic agent. It is formulated as capsules for oral route of administration. Baihuize is indicated for the treatment of patients with germline BRCA ...

BT-001 monotherapy showed stable disease and injected lesions shrinkage in advanced solid tumor patients. Promising efficacy ...

The FDA granted orphan drug designation for elraglusib, a novel drug for treating advanced soft tissue sarcoma.

Sarina Venable, a former Whitewater standout, a Miles Community College hall of famer and longtime high school basketball ...

BT-001 monotherapy showed stable disease and shrinkage of injected lesions in patients with advanced solid tumors. BT-001 in combination with ...